Literature DB >> 25171494

Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion.

Matthew J Furman1, Robert J Picotte, Mark J Wante, Barur R Rajeshkumar, Giles F Whalen, Laura A Lambert.   

Abstract

BACKGROUND/
OBJECTIVES: Heated intraperitoneal chemotherapy (HIPEC) kills cancer cells via thermal injury and improved chemotherapeutic cytotoxicity. We hypothesize that higher HIPEC flow rates improve peritoneal heating and HIPEC efficacy.
METHODS: (1) A HIPEC-model (30.8 L cooler with attached extracorporeal pump) was filled with 37°C water containing a suspended 1 L saline bag (SB) wrapped in a cooling sleeve, creating a constant heat sink. (2) HIPECs were performed in a swine model. Inflow, outflow, and peritoneal temperatures were monitored as flow rates varied. (3) Flow rates and temperatures during 20 HIPECs were reviewed.
RESULTS: Higher flow rates decreased time required to increase water bath (WB) and SB temperature to 43°C. With a constant heat sink, the minimum flow rate required to reach 43°C in the WB was 1.75 L/min. Higher flow rates lead to greater temperature gradients between the WB and SB. In the swine model, the minimum flow rate required to reach 43°C outflow was 2.5-3.0 L/min. Higher flows led to more rapid heating of the peritoneum and greater peritoneal/outflow temperature gradients. Increased flow during clinical HIPEC suggested improved peritoneal heating with lower average visceral temperatures.
CONCLUSIONS: There is a minimum flow rate required to reach goal temperature during HIPEC. Flow rate is an important variable in achieving and maintaining goal temperatures during HIPEC.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  chemosensitivity; flow rates; heat sink; heated intraperitoneal chemotherapy

Mesh:

Substances:

Year:  2014        PMID: 25171494     DOI: 10.1002/jso.23776

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

Review 1.  Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review.

Authors:  Mikhail Yu Reutovich; Olga V Krasko; Oleg G Sukonko
Journal:  J Gastrointest Oncol       Date:  2021-04

2.  A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function.

Authors:  Jinning Ye; Liuhua Chen; Jidong Zuo; Jianjun Peng; Chuangqi Chen; Shirong Cai; Wu Song; Yulong He; Yujie Yuan
Journal:  Cancer Biol Ther       Date:  2020-06-17       Impact factor: 4.742

3.  Simulating drug penetration during hyperthermic intraperitoneal chemotherapy.

Authors:  Daan R Löke; Roxan F C P A Helderman; Nicolaas A P Franken; Arlene L Oei; Pieter J Tanis; Johannes Crezee; H Petra Kok
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

4.  Abdominal tissue concentrations and penetration of carboplatin in a HIPEC procedure ‒ assessment in a novel porcine model.

Authors:  Elisabeth K Petersen; Mats Bue; Christina Harlev; Andrea R Jørgensen; Anne Schmedes; Pelle Hanberg; Lone K Petersen; Maiken Stilling
Journal:  Pleura Peritoneum       Date:  2022-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.